PREVALENCE OF HUMAN PAPILLOMAVIRUS, CYTOMEGALOVIRUS, AND EPSTEIN-BARR-VIRUS IN THE CERVIX OF HEALTHY WOMEN

Citation
A. Gradilone et al., PREVALENCE OF HUMAN PAPILLOMAVIRUS, CYTOMEGALOVIRUS, AND EPSTEIN-BARR-VIRUS IN THE CERVIX OF HEALTHY WOMEN, Journal of medical virology, 50(1), 1996, pp. 1-4
Citations number
21
Categorie Soggetti
Virology
Journal title
ISSN journal
01466615
Volume
50
Issue
1
Year of publication
1996
Pages
1 - 4
Database
ISI
SICI code
0146-6615(1996)50:1<1:POHPCA>2.0.ZU;2-1
Abstract
The prevalence of some sexually transmitted viruses, possibly involved in cervical carcinogenesis, was studied in the cervix of women with n ormal cytology. The presence of human papillomaviruses (HPV) type 16 a nd 18, cytomegalovirus (CMV) and Epstein-Barr virus (EBV) genomes in c ervical cells taken from 143 healthy Italian women was investigated us ing the polymerase chain reaction (PCR). The study population was divi ded into four groups with respect to age as follows: group I, 17 to 25 years, n = 48 women; group II, 26 to 35 years, n = 30; group III, 36 to 50 years, n = 32; and group IV, 51 to 70 years, n = 33. In the firs t age group prevalence rates of HPV 16, CMV and EBV infection of 23%, 21% and 19% were found respectively. The infection rates of HPV 16 and CMV were shown to decrease with age, with prevalences of HPV 16 at 10 % in the second group, 6% in the third and 3% in the fourth and of CMV at 13% in the second and third and 6% in the fourth groups. The preva lence of EBV infection did not decrease with increasing age (19% in th e first and third groups, 20% in the second and 18% in the fourth). Th e occurrence of HPV 18 genome was very low (0-3%) and independent of a ge. In the first age group a higher percentage of double infections (1 6.6%) was found than in the three other age groups (6% in the second a nd third and 3% in the fourth). The finding of multiple infections in younger women requires further study in order to clarify the implicati ons of such viral infections in healthy women and their contribution t o the development of genital tract malignancies. (C) 1996 Wiley-Liss, Inc.